BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15981303)

  • 1. Methods in pharmacoepidemiology: an invited series.
    Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):453-4. PubMed ID: 15981303
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficient sampling approaches to address confounding in database studies.
    Hanley JA; Dendukuri N
    Stat Methods Med Res; 2009 Feb; 18(1):81-105. PubMed ID: 18815164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Did thirst-blockers contribute to the exorbitant number of fatalities during the French 2003 heat wave?
    Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):312-3. PubMed ID: 18300324
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimal matching ratios in drug safety surveillance.
    Wang SV; Schneeweiss S; Rassen JA
    Epidemiology; 2014 Sep; 25(5):772-3. PubMed ID: 25076153
    [No Abstract]   [Full Text] [Related]  

  • 5. Approaches to combat with confounding by indication in observational studies of intended drug effects.
    McMahon AD
    Pharmacoepidemiol Drug Saf; 2003; 12(7):551-8. PubMed ID: 14558178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propensity scores in cardiovascular research.
    D'Agostino RB
    Circulation; 2007 May; 115(17):2340-3. PubMed ID: 17470708
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
    Etminan M; Gill S; Fitzgerald M; Samii A
    J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
    Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmeasured confounding in pharmacoepidemiology.
    Groenwold RH; de Groot MC; Ramamoorthy D; Souverein PC; Klungel OH
    Ann Epidemiol; 2016 Jan; 26(1):85-6. PubMed ID: 26559329
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of propensity score technique to account for exposure-related covariates: an example and lesson.
    Seeger JD; Kurth T; Walker AM
    Med Care; 2007 Oct; 45(10 Supl 2):S143-8. PubMed ID: 17909373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods in pharmacoepidemiology: time-varying drug effects revisited.
    Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):93-4. PubMed ID: 16447300
    [No Abstract]   [Full Text] [Related]  

  • 12. The case-crossover study design in pharmacoepidemiology.
    Delaney JA; Suissa S
    Stat Methods Med Res; 2009 Feb; 18(1):53-65. PubMed ID: 18765504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacoepidemiology].
    Hallas J; Sørensen HT
    Ugeskr Laeger; 2005 May; 167(20):2186-90. PubMed ID: 15987081
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
    Etminan M; Samii A
    Pharmacotherapy; 2004 Aug; 24(8):964-9. PubMed ID: 15338844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for good pharmacoepidemiology practices (GPP).
    ISPE
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):200-8. PubMed ID: 17868186
    [No Abstract]   [Full Text] [Related]  

  • 16. Invited commentary: Barker meets Simpson.
    Weinberg CR
    Am J Epidemiol; 2005 Jan; 161(1):33-5; discussion 36-7. PubMed ID: 15615911
    [No Abstract]   [Full Text] [Related]  

  • 17. Regression modelling and other methods to control confounding.
    McNamee R
    Occup Environ Med; 2005 Jul; 62(7):500-6, 472. PubMed ID: 15961628
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of health care databases in pharmacoepidemiology.
    Hennessy S
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: The Quasi-cohort Approach in Pharmaco epidemiology: Upgrading the Nested Case-control.
    Tanaka S; Noma H
    Epidemiology; 2016 Jan; 27(1):e1. PubMed ID: 26426940
    [No Abstract]   [Full Text] [Related]  

  • 20. Interpretation of associations in pharmacoepidemiology.
    Kaufman DW
    Semin Hematol; 2008 Jul; 45(3):181-8. PubMed ID: 18582625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.